 |
|
Evaluation of the role of ischemia modified albumin in neonatal hypoxic-ischemic encephalopathy
Mohamed A. Talat, Rabab M. Saleh, Mohammed M. Shehab, Naglaa A. Khalifa, Maha Mahmoud Hamed Sakr, Walaa M. Elmesalamy
Clin Exp Pediatr. 2020;63(8):329-334. Published online 2020 Aug 15 DOI: https://doi.org/10.3345/cep.2019.01410
|
|
Citations to this article as recorded by
 Ischemia‐modified albumin in rheumatic diseases: A systematic review and meta‐analysis
Arduino A. Mangoni, Angelo Zinellu
Immunity, Inflammation and Disease.2024;[Epub] CrossRef The Maternal, Cord Blood and Neonatal Serum Ischemia-Modified Albumin Levels in Different Modes of Delivery
Dilek ULUBAS ISİK, Sezin UNAL, Nihal DEMİREL, Yıldız AKDAŞ REİS, Özcan EREL, Ahmet Yağmur BAŞ
Türk Kadın Sağlığı ve Neonatoloji Dergisi.2023; 5(2): 35. CrossRef Rationale for the Use of Cord Blood in Hypoxic-Ischaemic Encephalopathy
Izabela Zdolińska-Malinowska, Dariusz Boruczkowski, Dominika Hołowaty, Paweł Krajewski, Emilian Snarski, Hector Mayani
Stem Cells International.2022; 2022: 1. CrossRef Diagnostic and Therapeutic Roles of the “Omics” in Hypoxic–Ischemic Encephalopathy in Neonates
Girish Kumar Rasineni, Nalinikanta Panigrahy, Subha Narayan Rath, Madhurarekha Chinnaboina, Ramesh Konanki, Dinesh Kumar Chirla, Srinivas Madduri
Bioengineering.2022; 9(10): 498. CrossRef Ischemia-Modified Albumin: Origins and Clinical Implications
Alla Shevtsova, Iuliia Gordiienko, Viktoriia Tkachenko, Galyna Ushakova, Heng Zhou
Disease Markers.2021; 2021: 1. CrossRef
|